Thanks Alex and Sebastian! Tregitope / IVIG connection reaffirmed!

What makes an unassuming girl from the East Side of Providence feel very important? When the Tregitope work done by her cutting-edge immunoinformatics company is re-affirmed by famous and powerful men. Thanks Alex Sette and Sebastian Spindeldreher! Before we get too … Continue reading

Posted in Blog | Tagged , , , , , | Leave a comment

Optimized H7N9 induces higher Ab in humanized, but not standard, mice

  A new article in Nature Scientific Reports (doi: 10.1038/s41598-017-01372-5) entitled A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines may explain why H7N9 influenza vaccines are consistently less immunogenic in humans than vaccines developed for … Continue reading

Posted in Blog, Featured, News | Tagged , , , , , , , , , , , | Leave a comment

Fearless Science at BIO2017

EpiVax will be in San Diego at the BIO international Convention, the most influential biotech convention in the industry. Look for us in the partnering system to arrange a meeting! After hours, we are hosting a networking reception at Puesto (Tuesday 20th, 7:00pm-9:30pm). Come unwind with … Continue reading

Posted in Blog, Events, Featured | Leave a comment

Happy Birthday EpiVax! We’re Celebrating With a New Look!

19 years ago EpiVax incorporated as a biotechnology company. In 2017, our business has never been stronger: the team is stacked with talent, collaborations are abundant and world-wide, and our in silico user base is extensive. We were recently recognized as one of … Continue reading

Posted in Blog, Featured, News | Leave a comment

BARDA, WHO, CDC and H7N9: Doing the Same Thing All Over Again?

“Insanity: doing the same thing over and over again and expecting different results.” – Albert Einstein. Due to its high rate of lethality (30-40%) and pandemic potential, H7N9 preparedness has become a priority for public health officials. While mutations that would enable … Continue reading

Posted in Blog, Featured, News | Tagged , , , , , , , , , , , | Leave a comment

Our Prediction for 2017: Out with Post Hoc and Go DeFT! 

It’s a new year and welcome to it! Pundits are making a lot of predictions about the decline of science and technology under the new administration in Washington DC, and I’m here with a contrarian view. We bet on biotechnology! We predict … Continue reading

Posted in Blog, Featured, News | Tagged , , , , , , | Leave a comment

Creating Locally, Thinking Globally

EpiVax is now a member of Eurobiomed , a community bringing together scientific thought leaders with a common mission: Improve the health of all and as  quickly as possible. EpiVax, as a key player in the development of immunotherapies, will be … Continue reading

Posted in Blog, Events | Leave a comment

The Ancer to Cancer: A computational pipeline for personalized cancer vaccine design

Building on 18 years of commercially successful research and development in the field of computational immunology, EpiVax has now developed Ancer™, a personalized cancer vaccine platform. Ancer is a high-speed, secure, cloud-based commercial platform for processing cancer/normal protein sets, identifying … Continue reading

Posted in Blog, EpiVax Immunoncology, Featured, News | Tagged , , , , , , , , , , , , | Leave a comment

9th Annual Biotech Showcase

Join us at Biotech Showcase! Partnering opportunities are available! Click Here to schedule. Get leading-edge information on our latest immunoinformatics platform: An Innovative Computational Pipeline for Personalized Cancer Vaccine Design With superior identification of neo-antigens, EpiVax is using our validated vaccine design … Continue reading

Posted in Blog, Events | Tagged , , , | Leave a comment

Bio-Europe Spring

EpiVax will be joining more than 1,400 companies from over 45 countries at Bio-Europe Spring, the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe’s most innovative biopharma clusters. Partner with us to … Continue reading

Posted in Blog, Events, Featured, News | Tagged , , , , , , | Leave a comment